Lupin Ltd.

1594.40 +14.40 ▲0.9%

25 April 2024, 04:05:35 PM
Volume: 1,203,147

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lupin.com
Market Cap 72,423.25 Cr.
Enterprise Value(EV) 74,203.37 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 39.30 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 40.44 Trailing Twelve Months Ending 2023-12
Industry PE 41.30 Trailing Twelve Months Ending 2023-12
Book Value / Share 304.06 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.23 Calculated using Price: 1,589.10
Dividend Yield 0.25 Period Ending 2023-03
No. of Shares Subscribed 45.58 Cr. 455,750,104 Shares
FaceValue 2
About Lupin Ltd.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. Lupin is recognised as one of the world's largest manufacturers of Tuberculosis drugs. The company have significant market share across multiple therapy areas such as Cardiovascular (prils and statins), Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro Intestinal (GI), Anti-Infective (AI) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). To add to this, the company has proud to maintain over the years its global leadership positions in other therapy areas such as Anti-TB and Cephalosporin.

Lupin Ltd. Delivery

Delivered Qty
Traded Qty

Lupin Ltd. Performance

1 Day
+0.91%
1 Week
-1.06%
1 Month
-0.86%
3 Month
+10.02%
6 Month
+36.51%
1 Year
+127.11%
2 Year
+111.40%
5 Year
+84.48%
10 Year
+61.59%

Lupin Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 31.09 22.85 21.05 1.94 3.88 -3.09 9.47 -11.79 3.68
Return on Capital Employed (%) 40.3 24.42 18.57 3.56 7.97 5.45 9.71 -7.11 6.06
Return on Assets (%) 21.08 12.84 10.6 1 1.97 -1.54 5.09 -6.7 2.01

Lupin Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8,874 11,163 13,498 13,577 13,742 12,537 13,803 12,153 12,465 13,239
Non Curr. Liab. 426 6,032 6,447 6,876 7,296 3,003 1,136 1,153 992 984
Curr. Liab. 3,729 5,061 6,121 5,096 6,130 9,225 8,436 8,276 9,265 8,921
Minority Int. 24 32 35 40 47 44 55 69 78 68
Equity & Liab. 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651 22,800 23,213
Non Curr. Assets 5,221 12,402 14,147 13,379 13,362 9,396 9,444 9,194 10,349 10,624
Curr. Assets 7,832 9,887 11,953 12,201 13,854 15,413 13,986 12,458 12,451 12,588
Misc. Exp. not W/O
Total Assets 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651 22,800 23,213

Lupin Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 12,770 14,139 17,494 15,804 14,665 15,375 15,163 16,405 16,642 19,480
Other Income 240 185 107 150 333 484 136 214 151 146
Total Income 13,010 14,324 17,601 15,955 14,998 15,859 15,299 16,619 16,793 19,626
Total Expenditure -9,150 -10,454 -13,001 -12,657 -12,104 -13,020 -12,596 -16,190 -14,921 -16,106
PBIDT 3,859 3,871 4,600 3,298 2,894 2,839 2,703 429 1,871 3,520
Interest -10 -59 -153 -204 -302 -363 -141 -143 -274 -333
Depreciation -435 -487 -912 -1,086 -846 -970 -887 -1,659 -881 -1,004
Taxation -970 -1,059 -979 -288 -888 -1,157 -449 -137 -269 -373
Exceptional Items -1,464 -340 -752
PAT 2,444 2,270 2,565 258 521 -400 1,228 -1,509 448 1,810
Minority Interest -41 -9 -7 -7 -9 0 -11 -19 -18 -19
Share Associate
Other Related Items
Consolidated Net Profit 2,403 2,261 2,557 251 607 -269 1,217 -1,528 430 1,791
Adjusted EPS 53 50 57 6 13 -6 27 -34 9 39

Lupin Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 2,004 2,733 -382 4,114 1,751 1,666 1,469 1,822 367 1,897
Cash Fr. Inv. -859 -1,055 -6,962 -2,527 470 -3,282 1,107 -1,240 1,292 -1,287
Cash Fr. Finan. -857 -197 5,836 433 -1,492 744 -891 -1,885 -1,572 -337
Net Change 288 1,482 -1,508 2,019 729 -872 1,685 -1,303 87 273
Cash & Cash Eqvt 607 2,108 780 2,799 1,416 544 2,229 926 1,013 1,265

Lupin Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 46.78 47.10 47.11 47.10 47.08 47.07 47.06 47.04 47.01
Public 53.22 52.90 52.89 52.90 52.92 52.93 52.94 52.96 52.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Lupin Ltd. Announcements

Thu, 25 Apr 2024
Loss of Share Certificates
Lupin Limited has informed the Exchange about Loss of Share Certificates
Thu, 25 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
LUPIN LIMITED has informed the Exchange about Loss of share certificates
Tue, 23 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Lupin Limited has informed the Exchange about Earnings Call for Q4 FY24 is scheduled on Tuesday, May 7, 2024 at 16:00 hrs (IST).

Lupin Ltd. Technical Scans

Wed, 24 Apr 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
CCI Oversold Zone CCI Oversold Zone

Lupin Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,520.15 +2.3%
Cipla Ltd. 112,292.49 1,406.20 +0.6%
Divi's Laboratories Ltd. 101,276.26 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,218.75 +4.5%
Mankind Pharma Ltd. 95,586.41 2,398.55 +0.0%
Zydus Lifesciences Ltd. 93,730.70 951.25 +1.9%
Torrent Pharmaceuticals Ltd. 90,650.92 2,694.30 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.28 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,694.30 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.34 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,694.30 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,694.30 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,694.30 +0.3%

Lupin Ltd. FAQ's

What is Lupin share price?

Can I buy Lupin shares now?

What is the Dividend Yield of Lupin?

What is the Market Cap of Lupin?

What are the key metrics to analyse Lupin?

What is the 52 Week High and Low of Lupin?

What is the trend of Lupin share price?